A randomised trial on combined low dose rt-PA and heparin versus heparin alone for treatment of patients with unstable angina pectoris
Romeo, F.; Martuscelli, E.; Lacquaniti, B.; Colistra, C.; Bianco, C.; Comito, M.; Miceli, M.; Lombardo, L.; Miceli, F.; Rosano, V.
Circulation 86(4 Suppl 1): I387
1992
ISSN/ISBN: 0009-7322
Accession: 029762639
PDF emailed within 1 workday: $29.90
Related References
Romeo F.; Rosano G.M.C.; Martuscelli E.; Lacquaniti B.; Colistra C.; Bianco C.; Comito M.; Miceli M.; Lombardo L.; Et Al 1992: Combined low dose rt pa and heparin versus heparin alone for treatment of patients with unstable angina pectoris a randomised trial European Heart Journal 13(ABSTR Suppl): 264Walsh, C.R.; Lloyd-Jones, D.M.; Camargo, C.A.; Giugliano, R.P.; O'Donnell, C.J. 2000: Clinical trials of unfractionated heparin and low-molecular-weight heparin in addition to aspirin for the treatment of unstable angina pectoris: Do the results apply to all patients? American Journal of Cardiology 86(9): 908-912
Turan, F.; Degertekin, M.; Gencbay, M.; Basaran, Y.; Yilmaz, H.; Dindar, I. 1998: Heparin-coated stent implantation in patients with unstable angina pectoris A randomized trial European Heart Journal 19(ABST Suppl ): 284
Sayen, J.J.; Singer, R.B.; Peirce, G.; Horwitz, O. 1983: Unstable angina, myocardial infarction, heparin and death: medium dose heparin (not exceeding 20,000 units/day) in the treatment of patients with acute coronary event--first year and long-term comparative mortality Transactions of the American Clinical and Climatological Association 94: 141-153
Aronov, D.; Zykova, V.; Vasilieva, E.; Avrusin, K. 1993: Low-molecular heparin Sulodexide vs heparin plus aspirin in unstable angina pectoris Cardiovascular Drugs and Therapy 7(Suppl 2): 462
Neri Serneri, G.G.; Modesti, P.A.; Gensini, G.F.; Branzi, A.; Melandri, G.; Poggesi, L.; Rostagno, C.; Tamburini, C.; Carnovali, M.; Magnani, B. 1995: Randomised comparison of subcutaneous heparin, intravenous heparin, and aspirin in unstable angina. Studio Epoorine Sottocutanea nell'Angina Instobile (SESAIR) Refrattorie Group Lancet 345(8959): 1201-1204
Ardissino, D.; Barberis, P.; De Servi, S.; Mussini, A.; Rolla, A.; Visani, L.; Specchia, G. 1990: Recombinant tissue-type plasminogen activator followed by heparin compared with heparin alone for refractory unstable angina pectoris American Journal of Cardiology 66(12): 910-914
Schulz, S.; Mehilli, J.; Ndrepepa, G.; Neumann, F.-J.; Birkmeier, K.A.; Kufner, S.; Richardt, G.; Berger, P.B.; Schömig, A.; Kastrati, A. 2010: Bivalirudin vs. unfractionated heparin during percutaneous coronary interventions in patients with stable and unstable angina pectoris: 1-year results of the ISAR-REACT 3 trial European Heart Journal 31(5): 582-587
Serneri, G.G. Neri; Modesti, P.A.; Gensini, G.F.; Branzi, A.; Melandri, G.; Poggesi, L.; Rostagno, C.; Tamburini, C.; Carnovali, M.; Magnani, B. 1995: Randomised comparison of subcutaneous heparin, intravenous heparin, and aspirin in unstable angina Lancet (North American Edition) 345(8959): 1201-1204
Bednarkiewicz, Z.; Krzeminska Pakula, M.; Kurpesa, M.; Trzos, E.; Peruga, J.; Religa, W. 1997: Low molecular weight heparin vs regular heparin in the treatment of patients with unstable angina Journal of the American College of Cardiology 29(2 Suppl A): 409A
Bucci, Marco; De Sanctis, Mariateresa; Cesarone, Maria R.; Incandela, Lucrezia; Griffin, Maura; Corsi, Marcello; Lennox, Andrew; Barsotti, Antonio; Nicolaides, Andrew N.; Belcaro, Gianni V. 2000: Treatment of patients with unstable angina with regular heparin vs low molecular weight heparin and vs LMWH+PGE1 Circulation 102(18): 2; 377
Oltrona, L.; Merlini, P.A.; Spinola, A.; Lombardo, M.; Granata, D.; Belii, C. 1993: A randomized trial on prolonged streptokinase infusion with concomitant heparin administration in unstable angina pectoris Circulation 88(4 Part 2): I608
Helber, U.; Beyer, M.E.; Heller, W.; Hoffmeister, H.M.rtin 1996: Increase of TAT after iv heparin therapy in patients with unstable angina pectoris Annals of Hematology 73(Suppl 1): S58
Steinberg, D.H.; Shah, P.; Kinnaird, T.; Pinto Slottow, T.L.; Roy, P.K.; Okabe, T.; Bonello, L.; de Labriolle, A.; Smith, K.A.; Torguson, R.; Xue, Z.; Suddath, W.O.; Kent, K.M.; Satler, L.F.; Pichard, A.D.; Lindsay, J.; Waksman, R. 2008: Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris American Journal of Cardiology 102(2): 160-164
Gurfinkel, E.; Cerda, M.; Manos, E.; Duronto, E.; Garcia, C.; Daroca, A.; Valdivieso, L.; Mautner, B. 1994: Reduction of recurrent angina and silent ischaemia in patients with unstable angina A pilot study using low molecular weight heparin, heparin or aspirin European Heart Journal 15(ABSTR Suppl ): 545